Symantec's purchase this week of Intel's antivirus business and licensing of its systems management technology has effectively killed off another market share hurdle and opens huge opportunities for the virus vendor to penetrate the corporate sector, senior executives claim.
Michelle Amery, Symantec general manager, Australia and New Zealand, said that under the deal the company would support Intel's 18,000 registered antivirus customers worldwide.
Amery declined to comment on how many antivirus customers Intel had in the local region, saying a report on the issue had only been partially completed.
She did, however, claim that the Intel deal would secure Symantec an extra 7 per cent share in the antivirus market. As part of the deal, Nortel AntiVirus engine technology is to be integrated into a new antivirus product that Intel is developing now. The product is, according to officials from the two vendors, expected to be fully integrated with Intel's LANDesk management suite and launched as a Norton AntiVirus product later this year. This, they said, would provide a smooth upgrade path for LANDesk Virus Protect customers.
Symantec said it would use the Intel systems management technology to help build the Digital Immune System being developed with neural network technologies from IBM.
An Intel Australia spokesperson said the decision represented another step in the vendor's strategy of licensing key components of its antivirus technology.